Our institution treated eight patients with SMARCB1-deficient sinonasal carcinoma between January 2014 and December 2021, with the database locked on 31st March 2022 (Supplementary Table S2). The gene discussed is SMARCB1; the disease is nasal cavity and paranasal sinus carcinoma.